Center Leadership

David Magnus, PhD,  is Thomas A. Raffin Professor of Medicine and Biomedical Ethics, and Professor of Pediatrics, Medicine, and by Courtesy of Bioengineering and Associate Dean of Research at Stanford University. He is the Director of the Stanford Center for Biomedical Ethics, a member of the Stanford Hospital and Clinics Ethics Committee, is past President of the Association of Bioethics Program Directors and is the Editor-in-Chief of the American Journal of Bioethics. He is currently the Vice-Chair of the IRB for the NIH Precision Medicine Initiative (“All of Us”).

Mildred Cho, PhD, Associate Director of the Center is also Professor of Pediatrics. Her major areas of interest are the ethical and social issues raised by new technologies such as genetic testing, gene therapy, pharmacogenetics, and gene patents. She also studies how academic-industry ties affect the conduct of biomedical research.

Henry Greely, JD, Chair of SCBE's Steering Committee, is Professor of Law and Professor, by courtesy, of Genetics at Stanford University. Specializing in health law and policy, Greely has written on cloning, the implications of genetics for the health care system, health care insurance and financing and the stem cell debate.

Thomas A. Raffin, MD, Co-Founder and Director Emeritus of the Center, is Colleen and Robert Haas Professor Emeritus of Medicine and Bioethics and former Chief of the Division of Pulmonary and Critical Care Medicine. In addition to biomedical ethics (withholding and withdrawing life support, medical decision-making in the context of managed care and HMOs, ethics of neurosciences, and ethical issues in human genetics), Dr. Raffin's other key areas of academic interest include the biology of acute lung injury, pulmonary fibrosis, and lymphangioleiomyomatosis.

Holly Tabor, PhD, is Associate Professor of Medicine at Stanford University. She is the Associate Director for Clinical Ethics and Education for the Stanford Center for Biomedical Ethics (SCBE) and is Co-Chair of the Ethics Committees at Stanford Hospital and Lucile Packard Children’s Hospital. Her research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing.